SBFM-PL4

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSBFM-PL4
Drug Alias NameSBFM-PL4
ClassificationSmall molecules
Mechanisms of ActionVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSunshine Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesSunshine Biopharma
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A